glp 1 ampule Five Unexpected New Uses for GLP-1 Receptor Agonists GLP-1 Medications: Everything You Need

openPR disclaims liability for any content contained in this release

Skov-Jeppesen K, Svane MS, Martinussen C, et al

Cognitive Functioning/Dementia At least 5 studies (1 case-control, 1 cohort, 3 RCTs) discussed the role of GLP-1 agonists and their action in AD and dementia

For many, this means dramatic weight loss often 1520% of body weight as well as improved blood sugar control

The ATTAIN-1 trial reported a mean change in body weight at 72 weeks of -11.2% with the highest dose of orforglipron 36 mg compared to -2.1% with placebo in adults with obesity or overweight and at least one weight-related comorbidity